Literature DB >> 12525274

Opioid resistance in chronic daily headache: a synthesis of ideas from the bench and bedside.

David M Biondi1.   

Abstract

Chronic daily headache is a complex pain disorder that encompasses many diagnostic and therapeutic challenges. Our understanding of the pathophysiologic processes of intermittent migraine has improved over the past decade, but the biologic basis of chronic daily headache remains obscure. Some of the more common issues confounding management of patients who experience chronic daily headache are medication overuse, psychiatric comorbidity, refractoriness to pharmacologic treatments, and disability. Long-acting opioid analgesics would appear to provide a viable treatment option for those patients who remain refractory to other treatment interventions; however, clinical experience often does not support this belief. Current concepts of the pathophysiologic basis of chronic pain and associated neural plasticity may elucidate a biologic basis for the general inefficacy of opioids in the management of chronic daily headache. This article explores the models of pathophysiology for migraine and chronic daily headache, the concept of chronic daily headache as a neuropathic pain syndrome, neural plasticity in the context of neuropathic pain states, the physiologic basis for opioid tolerance and opioid-induced hyperalgesia, and how each of these conditions interact to provoke the general lack of opioid efficacy often observed in the management of chronic daily headache.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12525274     DOI: 10.1007/s11916-003-0013-5

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  81 in total

Review 1.  Opioid tolerance-in search of the holy grail.

Authors:  Brigitte L Kieffer; Christopher J Evans
Journal:  Cell       Date:  2002-03-08       Impact factor: 41.582

Review 2.  Neuronal plasticity and signal transduction in nociceptive neurons: implications for the initiation and maintenance of pathological pain.

Authors:  R R Ji; C J Woolf
Journal:  Neurobiol Dis       Date:  2001-02       Impact factor: 5.996

3.  5HT in migraine patients with medication-induced headache.

Authors:  R Hering; V Glover; K Pattichis; T Catarci; T J Steiner
Journal:  Cephalalgia       Date:  1993-12       Impact factor: 6.292

Review 4.  Pathophysiology of migraine headache.

Authors:  S K Aurora
Journal:  Curr Pain Headache Rep       Date:  2001-04

5.  Changes in the expression of glial glutamate transporters in the rat brain accompanied with morphine dependence and naloxone-precipitated withdrawal.

Authors:  T Ozawa; T Nakagawa; K Shige; M Minami; M Satoh
Journal:  Brain Res       Date:  2001-06-29       Impact factor: 3.252

6.  Nitric oxide-induced headache in patients with chronic tension-type headache.

Authors:  M Ashina; L Bendtsen; R Jensen; J Olesen
Journal:  Brain       Date:  2000-09       Impact factor: 13.501

7.  Comparative study with EMG, pressure algometry and manual palpation in tension-type headache and migraine.

Authors:  G Sandrini; F Antonaci; E Pucci; G Bono; G Nappi
Journal:  Cephalalgia       Date:  1994-12       Impact factor: 6.292

8.  The antinociceptive action of paracetamol is associated with changes in the serotonergic system in the rat brain.

Authors:  L A Pini; M Sandrini; G Vitale
Journal:  Eur J Pharmacol       Date:  1996-07-11       Impact factor: 4.432

9.  Opioid receptor impairment--underlying mechanism in "pain diseases"?

Authors:  F Sicuteri
Journal:  Cephalalgia       Date:  1981-06       Impact factor: 6.292

10.  The loss of antinociceptive efficacy of spinal morphine in rats with nerve ligation injury is prevented by reducing spinal afferent drive.

Authors:  M H Ossipov; Y Lopez; M L Nichols; D Bian; F Porreca
Journal:  Neurosci Lett       Date:  1995-10-20       Impact factor: 3.046

View more
  7 in total

1.  Shared mechanisms for opioid tolerance and a transition to chronic pain.

Authors:  Elizabeth K Joseph; David B Reichling; Jon D Levine
Journal:  J Neurosci       Date:  2010-03-31       Impact factor: 6.167

Review 2.  What the pharmacological management of migraine can tell us about the future of migraine patient care.

Authors:  Paul B Rizzoli
Journal:  Neurol Sci       Date:  2018-06       Impact factor: 3.307

Review 3.  Is Medication Overuse Drug Specific or Not? Data from a Review of Published Literature and from an Original Study on Italian MOH Patients.

Authors:  Licia Grazzi; Eleonora Grignani; Domenico D'Amico; Emanuela Sansone; Alberto Raggi
Journal:  Curr Pain Headache Rep       Date:  2018-08-27

4.  Excitatory neurotransmitters in brain regions in interictal migraine patients.

Authors:  Andrew Prescot; Lino Becerra; Gautam Pendse; Shannon Tully; Eric Jensen; Richard Hargreaves; Perry Renshaw; Rami Burstein; David Borsook
Journal:  Mol Pain       Date:  2009-06-30       Impact factor: 3.395

5.  Migraine: an overview.

Authors:  Salvatore Salomone; Filippo Caraci; Anna Capasso
Journal:  Open Neurol J       Date:  2009-10-01

6.  The pharmacological management of migraine, part 1: overview and abortive therapy.

Authors:  George Demaagd
Journal:  P T       Date:  2008-07

Review 7.  Is migraine a neuropathic pain syndrome?

Authors:  David M Biondi
Journal:  Curr Pain Headache Rep       Date:  2006-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.